Kalaris Therapeutics, Inc. (NASDAQ:KLRS) IPO

Kalaris Therapeutics, Inc.

IPO

Went public as Allovir, Inc. Priced at US$17.00 a share on Jul 29, 2020.

Price
US$17.00 a share
Shares offered
16,250,000 shares of common stock
Offering size
US$276.3 million
Underwriters' option
Up to 2,437,500 more shares
Underwriters
MORGAN STANLEY, J.P. MORGAN, SVB LEERINK, PIPER SANDLER · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceJun 3, 2020
Filed publiclyJul 6, 2020
Amended onceJul 23, 2020
Shares registered with an exchangeJul 27, 2020
Declared effective by the SECJul 29, 2020
Final prospectus, with the priceJul 30, 2020

From the cover of the final prospectus (424B4) filed Jul 30, 2020